Page last updated: 2024-11-02

pioglitazone and Spinal Fractures

pioglitazone has been researched along with Spinal Fractures in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Spinal Fractures: Broken bones in the vertebral column.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Troostenburg de Bruyn, AR1
Dormandy, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
PROspective PioglitAzone Clinical Trial In MacroVascular Events: A Macrovascular Outcome Study in Type 2 Diabetic Patients Comparing Pioglitazone With Placebo in Addition to Existing Therapy[NCT00174993]Phase 34,373 participants (Actual)Interventional2001-05-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for pioglitazone and Spinal Fractures

ArticleYear
Risk of thiazolidinedione-associated fracture should be appropriately assessed.
    Archives of internal medicine, 2010, Jan-25, Volume: 170, Issue:2

    Topics: Female; Fractures, Spontaneous; Humans; Hypoglycemic Agents; Pioglitazone; Spinal Fractures; Thiazol

2010